Clinical Trials Directory

Trials / Conditions / Metastatic Oral Cavity Squamous Cell Carcinoma

Metastatic Oral Cavity Squamous Cell Carcinoma

8 registered clinical trials studyying Metastatic Oral Cavity Squamous Cell Carcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Nec
NCT06868433
Emory UniversityPhase 1
RecruitingTesting the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returni
NCT06589804
National Cancer Institute (NCI)Phase 3
RecruitingRemote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a
NCT06662058
Emory UniversityN/A
RecruitingLovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer,
NCT06636734
Emory UniversityPhase 2
Active Not RecruitingCombining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the
NCT05721755
ECOG-ACRIN Cancer Research GroupPhase 3
RecruitingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Mel
NCT05136196
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab)
NCT05172258
National Cancer Institute (NCI)Phase 2
Active Not RecruitingCemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcin
NCT04862650
Marcelo BonomiPhase 2